ABTEC — Aqua Bio Technology ASA Income Statement
0.000.00%
- NOK53.24m
- NOK131.78m
- NOK18.41m
Annual income statement for Aqua Bio Technology ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.891 | 0.444 | 1.56 | 7.02 | 18.4 |
Cost of Revenue | |||||
Gross Profit | -0.53 | -0.537 | 0.608 | 2.33 | 10.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 14 | 16.5 | 19.4 | 23.4 | 34.2 |
Operating Profit | -13.1 | -16.1 | -17.9 | -16.4 | -15.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13.2 | -15 | -19.1 | -18.8 | -20.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.2 | -14.7 | -19.1 | -18.7 | -21 |
Net Income Before Extraordinary Items | |||||
Net Income | -13.2 | -14.7 | -19.1 | -18.7 | -21 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.2 | -14.7 | -19.1 | -18.7 | -21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.02 | -0.907 | -0.993 | -0.906 | -0.67 |
Dividends per Share |